MERCK & CO., INC Rahway, NJ, USA
(known as MSD outside the United States and Canada)

Effective Nov. 20th, 2023 Caraway Therapeutics, Inc.,
a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

View the Announcement Visit

Scientific Advisors

James Summers
James B. Summers, PhD
Scientific Advisor
Former Vice President of Neuroscience Research, AbbVie

James B. Summers, PhD, has more than three decades of drug discovery and pharmaceutical research management experience spanning multiple therapeutic areas.

Under his leadership, teams have advanced more than 20 compounds into clinical development. He established new research sites in Cambridge, Massachusetts and Shanghai, China; was an architect of several strategies that defined the future direction of global research organizations; and championed multiple successful out-licensing deals, biotech collaborations and venture investments. He currently serves on the board of directors and as an advisor to several biotechnology companies

Dr. Summers has held various senior R&D leadership positions where he led efforts focused on the discovery of new drugs for the treatment of Alzheimer’s and Parkinson’s diseases, pain, and psychiatric disorders. Most recently, he was Vice President of Neuroscience Research at AbbVie. Dr. Summers also served as Divisional Vice President, Advanced Technology with Abbott where he was responsible for an organization engaged in a broad range of technologies and core services that enabled and accelerated drug discovery research across all of Abbott’s therapeutic areas and sites.

Dr. Summers holds a Bachelor of Science, summa cum laude, in chemistry from Denison University and a doctorate in organic chemistry from Harvard University.